Devin Carty
Co-Founder & Chairman of the Board @ Wellvana Health
Nashville, United States
Devin Carty is a seed investor at Wellvana Health in Nashville focused on Health Care and Medical. Devin Carty is the Chief Executive Officer of Martin Ventures. In this leadership capacity, Devin leads the investment committee and provides day-to-day oversight for all portfolio activity.Devin serves on the boards for several of the portfolio companies, including Lucro, Hashed Health, WiserTogether, Intervention Health Solutions, and JVION.Additionally, Devin is the Co-founder and Chairman of the Board for Trilliant Health. Trilliant Health is a technology, data analytics, and marketing company focused on helping healthcare providers grow profitable revenue through intelligent patient acquisition.Prior to Martin Ventures, Devin was the Co-founder and Chief Executive Officer of Clariture Health, Chief Strategy Officer & Chief Talent Officer for Cancer Treatment Centers of America, Chief Marketing Officer & Chief Experience Officer for Vanguard Health System, a Partner, overseeing healthcare consulting for Gallup, the Head of New Product Development & Growth for PRNewswire/United Business Media, and a Scientist with NASA.
- Total investments:
- 9
- Last investment:
- Lead investor:
- 33%
Last updated:
For AI agents: llms.txt
Industries Devin Carty invests in
Stages Devin Carty invests in
Countries Devin Carty invests in
Investment Focus
Industry
- Health Care 5 (56%)
- Medical 4 (44%)
- Oncology 3 (33%)
- Software 2 (22%)
- Medical Device 2 (22%)
Stage
- Seed 3 (33%)
- Series A 2 (22%)
- Series B 1 (11%)
- Funding Round 1 (11%)
- Venture - Series Unknown 1 (11%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
OncoLens
|
OncoLens develops technologies that improve cancer treatment planning, simplify tumor board management, facilitate survivorship care planning, and automate accreditation and quality reporting through an intelligent workflow engine that streamlines business processes and enables more informed clinical decision-making. | $16M / Series B / Oct 24, 2024 | |
StationMD
|
Our telemedicine solution at StationMD delivers superior care to the most vulnerable populations while also reducing unnecessary hospital use. Our secure video-conferencing system, augmented by sophisticated diagnostic tools, is combined with clinical expertise to evaluate and treat patients in their home environment—whether that is a nursingfacility, group home or any residential setting. Our platform allows us to partner with any patient group or facility throughout the United States. | $3.2M / Venture - Series Unknown / Mar 31, 2022 | |
Valar Labs
|
Valar Labs makes AI to interpret solid tumors and deliver insights, so physicians and patients can make informed treatment decisions. Their AI algorithms analyze digitized pathology slides to assess spatial features, and they design transparent systems grounded in underlying biology so physicians can trust the results. | $4M / Seed / Mar 30, 2022 | |
Reimagine Care
|
Reimagine Care is a health care company that provides technology-enabled services to support community-based oncology care settings. It aims to make high-quality cancer care more affordable, accessible, and patient-centric. Reimagine Care partners with HC systems and independent physician oncology practices to support value-based oncology caredelivery in the community. They do this by providing the people, processes, and a robust technology platform that enables the scalable and effective delivery of high-quality, patient-centric, lower-cost cancer care across multiple care sites, including the home.It was founded in 2020 and is based in Nashville, Tennessee. | $25M / Series A / Jan 25, 2022 | |
Mployer Advisor
|
Mployer Advisor is the independent platform for employers to research, review and evaluate insurance brokers. | $1.6M / Seed / Nov 02, 2021 | |
Memora Health
|
Memora Health, the leading intelligent care enablement platform, helps clinicians focus on top-of-license practice while proactively engaging patients along complex care journeys. Memora partners with leading health systems, health plans, and digital health companies to transform the care delivery process for care teams and patients. Our platformdigitizes and automates high-touch clinical workflows, supercharging care teams by intelligently triaging patient-reported concerns and data to appropriate care team members and providing patients with proactive, two-way communication and support. Memora Health is headquartered in San Francisco, CA, with clients and team members around the country, and is backed by Andreessen Horowitz, Transformation Capital, General Catalyst, AlleyCorp, Frist Cressey Ventures, Martin Ventures, Kevin Durant and Rich Kleiman's Thirty Five Ventures, and several other strategic healthcare groups.To learn more about Memora’s vision to make care more actionable, accessible and always-on, visit memorahealth.com. | $10.5M / May 11, 2021 | |
|
Memora Health
|
Memora Health, the leading intelligent care enablement platform, helps clinicians focus on top-of-license practice while proactively engaging patients along complex care journeys. Memora partners with leading health systems, health plans, and digital health companies to transform the care delivery process for care teams and patients. Our platformdigitizes and automates high-touch clinical workflows, supercharging care teams by intelligently triaging patient-reported concerns and data to appropriate care team members and providing patients with proactive, two-way communication and support. Memora Health is headquartered in San Francisco, CA, with clients and team members around the country, and is backed by Andreessen Horowitz, Transformation Capital, General Catalyst, AlleyCorp, Frist Cressey Ventures, Martin Ventures, Kevin Durant and Rich Kleiman's Thirty Five Ventures, and several other strategic healthcare groups.To learn more about Memora’s vision to make care more actionable, accessible and always-on, visit memorahealth.com. | $10.5M / Seed / May 11, 2021 | |
|
OncoLens
|
OncoLens develops technologies that improve cancer treatment planning, simplify tumor board management, facilitate survivorship care planning, and automate accreditation and quality reporting through an intelligent workflow engine that streamlines business processes and enables more informed clinical decision-making. | $7.3M / Series A / Jan 14, 2021 | |
|
Mployer Advisor
|
Mployer Advisor is the independent platform for employers to research, review and evaluate insurance brokers. | Seed / Dec 02, 2020 |
Co-Investors
About Wellvana Health
Wellvana is a hospital and healthcare that specialized in providing the required infrastructure to enable the collaboration of independent medical providers to improve healthcare quality, cost, and patient experience. Its services also offer a platform for providers to actively shape their future and provides patients with the right care, in theright care setting.The company was founded in 2018 and headquartered in San Antonio, Texas.
Wellvana Health Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Devin Carty
Co-Founder & Chairman of the Board
|
|||
Mark Montoney
Chief Medical Officer
|
|||
|
Jairo Melo
Chief Medical Officer & Co Founder
|
|||
Kyle Wailes
Chief Executive Officer
|
|||
1 more contact available
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Devin Carty invest in?
Devin Carty invests primarily in Health Care, Medical and Oncology startups, most often at Seed and Series A stage. Most of the 9 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Devin Carty last invest?
The most recent investment recorded for Devin Carty closed in Oct 2024. Shizune tracks 9 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
